TOKYO, Feb 10 (Reuters) - Takeda Pharmaceutical Co, Japan’s largest drugmaker, and U.S. firm Xoma Ltd said on Tuesday they would expand their partnership to give Takeda access to Xoma’s multiple antibody technologies.
TOKYO, Feb 10 (Reuters) - Takeda Pharmaceutical Co, Japan’s largest drugmaker, and U.S. firm Xoma Ltd said on Tuesday they would expand their partnership to give Takeda access to Xoma’s multiple antibody technologies.
